<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34556702</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Neuronal mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis is developmentally regulated.</ArticleTitle><Pagination><StartPage>18916</StartPage><MedlinePgn>18916</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">18916</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-97928-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is an adult-onset neurodegenerative disorder characterized by loss of motor neurons. Mitochondria are essential for neuronal survival but the developmental timing and mechanistic importance of mitochondrial dysfunction in sporadic ALS (sALS) neurons is not fully understood. We used human induced pluripotent stem cells and generated a developmental timeline by differentiating sALS iPSCs to neural progenitors and to motor neurons and comparing mitochondrial parameters with familial ALS (fALS) and control cells at each developmental stage. We report that sALS and fALS motor neurons have elevated reactive oxygen species levels, depolarized mitochondria, impaired oxidative phosphorylation, ATP loss and defective mitochondrial protein import compared with control motor neurons. This phenotype develops with differentiation into motor neurons, the affected cell type in ALS, and does not occur in the parental undifferentiated sALS cells or sALS neural progenitors. Our work demonstrates a developmentally regulated unifying mitochondrial phenotype between patient derived sALS and fALS motor neurons. The occurrence of a unifying mitochondrial phenotype suggests that mitochondrial etiology known to SOD1-fALS may applicable to sALS. Furthermore, our findings suggest that disease-modifying treatments focused on rescue of mitochondrial function may benefit both sALS and fALS patients.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Singh</LastName><ForeName>Tanisha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, B400 Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jiao</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, B400 Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrando</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, B400 Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yablonska</LastName><ForeName>Svitlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, B400 Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, B400 Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horoszko</LastName><ForeName>Emily C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, B400 Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacomis</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, University of Pittsburgh, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedlander</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, B400 Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlisle</LastName><ForeName>Diane L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, B400 Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA, 15213, USA. DLC4@pitt.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="Y">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058953" MajorTopicYN="N">Neural Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Dr. Friedlander is on the advisory board of neubase therapeutics (NBSE) and Dr. Carlisle is a scientific consultant for NBSE, both in the area of Huntington&#x2019;s disease which is unrelated to this study. No other authors have interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34556702</ArticleId><ArticleId IdType="pmc">PMC8460779</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-97928-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-97928-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2014;10:661. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, et al. Amyotrophic lateral sclerosis. The Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 2006;7:710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt MF, et al. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol. Cell. Neurosci. 2013;56:355&#x2013;364. doi: 10.1016/j.mcn.2013.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2013.07.007</ArticleId><ArticleId IdType="pmc">PMC4772428</ArticleId><ArticleId IdType="pubmed">23891805</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R, Mariotti R. ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles. Front. Cell. Neurosci. 2017;11:80. doi: 10.3389/fncel.2017.00080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00080</ArticleId><ArticleId IdType="pmc">PMC5359305</ArticleId><ArticleId IdType="pubmed">28377696</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M, et al. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta Neuropathol. 2019;137:47&#x2013;69. doi: 10.1007/s00401-018-1934-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1934-8</ArticleId><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaus A, Sareen D. ALS patient stem cells for unveiling disease signatures of motoneuron susceptibility: perspectives on the deadly mitochondria, ER stress and calcium triad. Front. Cell. Neurosci. 2015;9:448. doi: 10.3389/fncel.2015.00448.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00448</ArticleId><ArticleId IdType="pmc">PMC4652136</ArticleId><ArticleId IdType="pubmed">26635528</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J, Manfredi G. Mitochondrial function, morphology, and axonal transport in amyotrophic lateral sclerosis. Antioxid. Redox Signal. 2009;11:1615&#x2013;1626. doi: 10.1089/ars.2009.2604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2604</ArticleId><ArticleId IdType="pmc">PMC2789440</ArticleId><ArticleId IdType="pubmed">19344253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaya T, Maragkakis M. Amyotrophic lateral sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity. Sci. Rep. 2018;8:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6197261</ArticleId><ArticleId IdType="pubmed">30349096</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc. 1992;31:119&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">1349466</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredi G, Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion. 2005;5:77&#x2013;87. doi: 10.1016/j.mito.2005.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2005.01.002</ArticleId><ArticleId IdType="pubmed">16050975</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C-H, Wu S-B, Wu Y-T, Wei Y-H. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp. Biol. Med. 2013;238:450&#x2013;460. doi: 10.1177/1535370213493069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370213493069</ArticleId><ArticleId IdType="pubmed">23856898</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. 1997;94:514&#x2013;519. doi: 10.1073/pnas.94.2.514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.2.514</ArticleId><ArticleId IdType="pmc">PMC19544</ArticleId><ArticleId IdType="pubmed">9012815</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano M, et al. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. J. Neurochem. 2006;96:1349&#x2013;1361. doi: 10.1111/j.1471-4159.2006.03619.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03619.x</ArticleId><ArticleId IdType="pubmed">16478527</ArticleId></ArticleIdList></Reference><Reference><Citation>Hervias I, Beal MF, Manfredi G. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve Off. J. Am. Assoc. Electrodiagn. Med. 2006;33:598&#x2013;608. doi: 10.1002/mus.20489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20489</ArticleId><ArticleId IdType="pubmed">16372325</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, et al. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc. Natl. Acad. Sci. 2010;107:21146&#x2013;21151. doi: 10.1073/pnas.1014862107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014862107</ArticleId><ArticleId IdType="pmc">PMC3000256</ArticleId><ArticleId IdType="pubmed">21078990</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrane J, Cortez C, Gan W-B, Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, et al. Poly (GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, et al. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10 S59L/+ mouse. Acta Neuropathol. 2019;138:123&#x2013;145. doi: 10.1007/s00401-019-01988-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01988-z</ArticleId><ArticleId IdType="pubmed">30874923</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhaliwal GK, Grewal RP. Mitochondrial DNA deletion mutation levels are elevated in ALS brains. NeuroReport. 2000;11:2507&#x2013;2509. doi: 10.1097/00001756-200008030-00032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200008030-00032</ArticleId><ArticleId IdType="pubmed">10943712</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzardini M, Lupi M, Bernasconi S, Mangolini A, Cantoni L. Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid. J. Neurol. Sci. 2003;207:51&#x2013;58. doi: 10.1016/S0022-510X(02)00357-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(02)00357-X</ArticleId><ArticleId IdType="pubmed">12614931</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z, Wang W, Perry G, Zhu X, Wang X. Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis. Transl. Neurodegener. 2015;4:1&#x2013;6. doi: 10.1186/s40035-015-0037-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-015-0037-x</ArticleId><ArticleId IdType="pmc">PMC4518588</ArticleId><ArticleId IdType="pubmed">26225210</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera TW, Borges K. Metabolic dysfunctions in amyotrophic lateral sclerosis pathogenesis and potential metabolic treatments. Front. Neurosci. 2017;10:611. doi: 10.3389/fnins.2016.00611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00611</ArticleId><ArticleId IdType="pmc">PMC5222822</ArticleId><ArticleId IdType="pubmed">28119559</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Song J, Huang H, Chen H, Qian K. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells. Stem Cell Res. Ther. 2018;9:1&#x2013;14. doi: 10.1186/s13287-017-0735-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-017-0735-7</ArticleId><ArticleId IdType="pmc">PMC6238404</ArticleId><ArticleId IdType="pubmed">30442180</ArticleId></ArticleIdList></Reference><Reference><Citation>Delic V, et al. Discrete mitochondrial aberrations in the spinal cord of sporadic ALS patients. J. Neurosci. Res. 2018;96:1353&#x2013;1366. doi: 10.1002/jnr.24249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24249</ArticleId><ArticleId IdType="pubmed">29732581</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CJ, et al. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front. Cell. Neurosci. 2015;9:289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4523944</ArticleId><ArticleId IdType="pubmed">26300727</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak J, et al. Distinction of sporadic and familial forms of ALS based on mitochondrial characteristics. FASEB J. 2019;33:4388&#x2013;4403. doi: 10.1096/fj.201801843R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201801843R</ArticleId><ArticleId IdType="pubmed">30550341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk K, et al. Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients. Ann. Neurol. 2014;76:620&#x2013;624. doi: 10.1002/ana.24244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24244</ArticleId><ArticleId IdType="pmc">PMC4192005</ArticleId><ArticleId IdType="pubmed">25090982</ArticleId></ArticleIdList></Reference><Reference><Citation>Varum S, et al. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PloS One. 2011;6:e20914. doi: 10.1371/journal.pone.0020914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020914</ArticleId><ArticleId IdType="pmc">PMC3117868</ArticleId><ArticleId IdType="pubmed">21698063</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YM, et al. Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem. Biophys. Res. Commun. 2006;348:1472&#x2013;1478. doi: 10.1016/j.bbrc.2006.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.08.020</ArticleId><ArticleId IdType="pubmed">16920071</ArticleId></ArticleIdList></Reference><Reference><Citation>Lees JG, Rathjen J, Sheedy JR, Gardner DK, Harvey AJ. Distinct profiles of human embryonic stem cell metabolism and mitochondria identified by oxygen. Science. 2015;2:19.</Citation><ArticleIdList><ArticleId IdType="pubmed">26159831</ArticleId></ArticleIdList></Reference><Reference><Citation>Teslaa T, Teitell MA. Pluripotent stem cell energy metabolism: an update. EMBO J. 2015;34:138&#x2013;153. doi: 10.15252/embj.201490446.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490446</ArticleId><ArticleId IdType="pmc">PMC4337063</ArticleId><ArticleId IdType="pubmed">25476451</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien LC, Keeney PM, Bennett JP., Jr Differentiation of human neural stem cells into motor neurons stimulates mitochondrial biogenesis and decreases glycolytic flux. Stem Cells Dev. 2015;24:1984&#x2013;1994. doi: 10.1089/scd.2015.0076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2015.0076</ArticleId><ArticleId IdType="pmc">PMC4545371</ArticleId><ArticleId IdType="pubmed">25892363</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, et al. Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation. Elife. 2016;5:e13374. doi: 10.7554/eLife.13374.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.13374</ArticleId><ArticleId IdType="pmc">PMC4963198</ArticleId><ArticleId IdType="pubmed">27282387</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, &#xd6;zdinler PH, Kiernan MC, Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat. Rev. Neurol. 2016;12:651. doi: 10.1038/nrneurol.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann FR, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 1998;156:65&#x2013;72. doi: 10.1016/S0022-510X(98)00008-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00008-2</ArticleId><ArticleId IdType="pubmed">9559989</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M, et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002;277:29626&#x2013;29633. doi: 10.1074/jbc.M203065200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc. 1999;46:787&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">10553999</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, et al. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiol. Aging. 2014;35:1499&#x2013;1509. doi: 10.1016/j.neurobiolaging.2013.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.11.025</ArticleId><ArticleId IdType="pubmed">24439480</ArticleId></ArticleIdList></Reference><Reference><Citation>Valbuena GN, et al. Metabolomic analysis reveals increased aerobic glycolysis and amino acid deficit in a cellular model of amyotrophic lateral sclerosis. Mol. Neurobiol. 2016;53:2222&#x2013;2240. doi: 10.1007/s12035-015-9165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9165-7</ArticleId><ArticleId IdType="pmc">PMC4823370</ArticleId><ArticleId IdType="pubmed">25963727</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimos JT, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;321:1218&#x2013;1221. doi: 10.1126/science.1158799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1158799</ArticleId><ArticleId IdType="pubmed">18669821</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S, et al. Characterization of the mitochondrial Aerobic metabolism in the pre-and perisynaptic districts of the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Mol. Neurobiol. 2018;55:9220&#x2013;9233. doi: 10.1007/s12035-018-1059-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1059-z</ArticleId><ArticleId IdType="pubmed">29656361</ArticleId></ArticleIdList></Reference><Reference><Citation>Sances S, et al. Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat. Neurosci. 2016;19:542&#x2013;553. doi: 10.1038/nn.4273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4273</ArticleId><ArticleId IdType="pmc">PMC5015775</ArticleId><ArticleId IdType="pubmed">27021939</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowling AC, Beal MF. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 1995;56:1151&#x2013;1171. doi: 10.1016/0024-3205(95)00055-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(95)00055-B</ArticleId><ArticleId IdType="pubmed">7475893</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedlander RM, Brown RH, Gagliardini V, Wang J, Yuan J. Inhibition of ICE slows ALS in mice. Nature. 1997;388:31&#x2013;31. doi: 10.1038/40299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/40299</ArticleId><ArticleId IdType="pubmed">9214497</ArticleId></ArticleIdList></Reference><Reference><Citation>Egawa N, et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 2012;4:145ra104. doi: 10.1126/scitranslmed.3004052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004052</ArticleId><ArticleId IdType="pubmed">22855461</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson K, et al. The effect of SOD1 mutation on cellular bioenergetic profile and viability in response to oxidative stress and influence of mutation-type. PLoS One. 2013;8:e68256. doi: 10.1371/journal.pone.0068256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0068256</ArticleId><ArticleId IdType="pmc">PMC3695905</ArticleId><ArticleId IdType="pubmed">23840839</ArticleId></ArticleIdList></Reference><Reference><Citation>Turakhiya U, et al. Protein import by the mitochondrial presequence translocase in the absence of a membrane potential. J. Mol. Biol. 2016;428:1041&#x2013;1052. doi: 10.1016/j.jmb.2016.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2016.01.020</ArticleId><ArticleId IdType="pubmed">26827728</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin J, Mahlke K, Pfanner N. Role of an energized inner membrane in mitochondrial protein import. Delta psi drives the movement of presequences. J. Biol. Chem. 1991;266:18051&#x2013;18057. doi: 10.1016/S0021-9258(18)55235-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)55235-2</ArticleId><ArticleId IdType="pubmed">1833391</ArticleId></ArticleIdList></Reference><Reference><Citation>Geissler A, et al. Membrane potential-driven protein import into mitochondria: the sorting sequence of cytochrome b 2Modulates the &#x394;&#x3c8;-dependence of translocation of the matrix-targeting sequence. Mol. Biol. Cell. 2000;11:3977&#x2013;3991. doi: 10.1091/mbc.11.11.3977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.11.11.3977</ArticleId><ArticleId IdType="pmc">PMC15051</ArticleId><ArticleId IdType="pubmed">11071921</ArticleId></ArticleIdList></Reference><Reference><Citation>Yano H, et al. Inhibition of mitochondrial protein import by mutant huntingtin. Nat. Neurosci. 2014;17:822&#x2013;831. doi: 10.1038/nn.3721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3721</ArticleId><ArticleId IdType="pmc">PMC4174557</ArticleId><ArticleId IdType="pubmed">24836077</ArticleId></ArticleIdList></Reference><Reference><Citation>Boengler K, Heusch G, Schulz R. Nuclear-encoded mitochondrial proteins and their role in cardioprotection. Biochimica et Biophysica Acta (BBA) Mol. Cell Res. 2011;1813:1286&#x2013;1294. doi: 10.1016/j.bbamcr.2011.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2011.01.009</ArticleId><ArticleId IdType="pubmed">21255616</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N. Importing mitochondrial proteins: machineries and mechanisms. Cell. 2009;138:628&#x2013;644. doi: 10.1016/j.cell.2009.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.08.005</ArticleId><ArticleId IdType="pmc">PMC4099469</ArticleId><ArticleId IdType="pubmed">19703392</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo T, Yamano K. Multiple pathways for mitochondrial protein traffic. Biol. Chem. 2009;390:723&#x2013;730. doi: 10.1515/BC.2009.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/BC.2009.087</ArticleId><ArticleId IdType="pubmed">19453276</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z, Patten SA. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2019;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco-Iborra S, et al. Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson&#x2019;s disease. Cell Death Dis. 2018;9:1&#x2013;17. doi: 10.1038/s41419-018-1154-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1154-0</ArticleId><ArticleId IdType="pmc">PMC6221944</ArticleId><ArticleId IdType="pubmed">30405116</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat P-F, Ludolph AC, Loeffler J-P. Energy metabolism in amyotrophic lateral sclerosis. The Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hor J-H, et al. ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation. Cell Death Differ. 2020;6:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027637</ArticleId><ArticleId IdType="pubmed">33184465</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangaraju V, Calloway N, Ryan TA. Activity-driven local ATP synthesis is required for synaptic function. Cell. 2014;156:825&#x2013;835. doi: 10.1016/j.cell.2013.12.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.12.042</ArticleId><ArticleId IdType="pmc">PMC3955179</ArticleId><ArticleId IdType="pubmed">24529383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ames A., III CNS energy metabolism as related to function. Brain Res. Rev. 2000;34:42&#x2013;68. doi: 10.1016/S0165-0173(00)00038-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-0173(00)00038-2</ArticleId><ArticleId IdType="pubmed">11086186</ArticleId></ArticleIdList></Reference><Reference><Citation>Erecinska M, Cherian S, Silver IA. Energy metabolism in mammalian brain during development. Prog. Neurobiol. 2004;73:397&#x2013;445. doi: 10.1016/j.pneurobio.2004.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2004.06.003</ArticleId><ArticleId IdType="pubmed">15313334</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly NM, D&#xfc;ssmann H, Anilkumar U, Huber HJ, Prehn JH. Single-cell imaging of bioenergetic responses to neuronal excitotoxicity and oxygen and glucose deprivation. J. Neurosci. 2014;34:10192&#x2013;10205. doi: 10.1523/JNEUROSCI.3127-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3127-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608276</ArticleId><ArticleId IdType="pubmed">25080581</ArticleId></ArticleIdList></Reference><Reference><Citation>Yablonska S, et al. Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23. Proc. Natl. Acad. Sci. 2019;116:16593&#x2013;16602. doi: 10.1073/pnas.1904101116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1904101116</ArticleId><ArticleId IdType="pmc">PMC6697818</ArticleId><ArticleId IdType="pubmed">31346086</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861&#x2013;872. doi: 10.1016/j.cell.2007.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.11.019</ArticleId><ArticleId IdType="pubmed">18035408</ArticleId></ArticleIdList></Reference><Reference><Citation>Holler CJ, et al. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia. Mol. Neurodegener. 2016;11:1&#x2013;17. doi: 10.1186/s13024-016-0114-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0114-3</ArticleId><ArticleId IdType="pmc">PMC4919863</ArticleId><ArticleId IdType="pubmed">27341800</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Laan M, et al. A role for Tim21 in membrane-potential-dependent preprotein sorting in mitochondria. Curr. Biol. 2006;16:2271&#x2013;2276. doi: 10.1016/j.cub.2006.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2006.10.025</ArticleId><ArticleId IdType="pubmed">17113393</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirrenberg C, Bauer MF, Guiard B, Neupert W, Brunner M. Import of carrier proteins into the mitochondrial inner membrane mediated by Tim22. Nature. 1996;384:582&#x2013;585. doi: 10.1038/384582a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/384582a0</ArticleId><ArticleId IdType="pubmed">8955274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 2019;15:e1007947. doi: 10.1371/journal.pgen.1007947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R, et al. C9orf72 hexanucleotide expansions are associated with altered endoplasmic reticulum calcium homeostasis and stress granule formation in induced pluripotent stem cell-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal dementia. Stem cells. 2016;34:2063&#x2013;2078. doi: 10.1002/stem.2388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2388</ArticleId><ArticleId IdType="pmc">PMC4979662</ArticleId><ArticleId IdType="pubmed">27097283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladd AC, Keeney PM, Govind MM, Bennett JP. Mitochondrial oxidative phosphorylation transcriptome alterations in human amyotrophic lateral sclerosis spinal cord and blood. NeuroMol. Med. 2014;16:714&#x2013;726. doi: 10.1007/s12017-014-8321-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-014-8321-y</ArticleId><ArticleId IdType="pubmed">25081190</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkinezos IG, et al. Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J. Neurosci. 2005;25:164&#x2013;172. doi: 10.1523/JNEUROSCI.3829-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3829-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725219</ArticleId><ArticleId IdType="pubmed">15634778</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung C, Higgins CM, Xu Z. Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J. Neurochem. 2002;83:535&#x2013;545. doi: 10.1046/j.1471-4159.2002.01112.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01112.x</ArticleId><ArticleId IdType="pubmed">12390515</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol. 2018;135:489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 2002;80:616&#x2013;625. doi: 10.1046/j.0022-3042.2001.00731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeatts K. Disease Gene Identification. Berlin: Springer; 2011. pp. 171&#x2013;184.</Citation></Reference><Reference><Citation>Singh S, Zhuo M, Gorgun FM, Englander EW. Overexpressed neuroglobin raises threshold for nitric oxide-induced impairment of mitochondrial respiratory activities and stress signaling in primary cortical neurons. Nitric Oxide. 2013;32:21&#x2013;28. doi: 10.1016/j.niox.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.niox.2013.03.008</ArticleId><ArticleId IdType="pmc">PMC3816961</ArticleId><ArticleId IdType="pubmed">23587847</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg TK, Chang JY. 15-deoxy-delta 12, 14-Prostaglandin J 2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress. BMC Pharmacol. 2004;4:6. doi: 10.1186/1471-2210-4-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2210-4-6</ArticleId><ArticleId IdType="pmc">PMC446193</ArticleId><ArticleId IdType="pubmed">15149553</ArticleId></ArticleIdList></Reference><Reference><Citation>Little D, et al. Cell-Based Assays Using iPSCs for Drug Development and Testing. Springer; 2019. pp. 175&#x2013;184.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>